Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommerer

Showing results (401-410 of 427) with videos related to

Pageof 43
Sort By:
Plos One|August 21, 2018
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Plos One|September 14, 2018
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
BMC Nephrology|June 12, 2016
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohortMartin Busch, Jennifer Nadal, Matthias Schmid, et al.
International Journal of Cancer|April 23, 2019
Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures-Gender mattersChristina U Köhler, Nadine Bonberg, Maike Ahrens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 29, 2017
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational studyBernhard Banas, Dominik Steubl, Lutz Renders, et al.
BMC Nephrology|September 21, 2018
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trialsClaudia Sommerer, Oliver Witzke, Frank Lehner, et al.
Kidney International Reports|May 16, 2022
Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the German CKD (GCKD) CohortDoris Winitzki, Helena U Zacharias, Jennifer Nadal, et al.
Pharmaceutics|September 28, 2024
Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral StrategiesDebora Obergfäll, Markus Wild, Mona Sommerer, et al.
G3 (Bethesda, Md.)|April 29, 2022
A genome-wide association and prediction study in grapevine deciphers the genetic architecture of multiple traits and identifies genes under many new QTLsTimothée Flutre, Loïc Le Cunff, Agota Fodor, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2014
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS studyFrank Lehner, Klemens Budde, Martin Zeier, et al.
Pageof 43

Showing results (401-410 of 427) with videos related to

Sort By:
Pageof 43
Plos One|August 21, 2018
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
Plos One|September 14, 2018
Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) studyMarkus P Schneider, Karl F Hilgers, Matthias Schmid, et al.
BMC Nephrology|June 12, 2016
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohortMartin Busch, Jennifer Nadal, Matthias Schmid, et al.
International Journal of Cancer|April 23, 2019
Noninvasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures-Gender mattersChristina U Köhler, Nadine Bonberg, Maike Ahrens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 29, 2017
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational studyBernhard Banas, Dominik Steubl, Lutz Renders, et al.
BMC Nephrology|September 21, 2018
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trialsClaudia Sommerer, Oliver Witzke, Frank Lehner, et al.
Kidney International Reports|May 16, 2022
Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in the German CKD (GCKD) CohortDoris Winitzki, Helena U Zacharias, Jennifer Nadal, et al.
Pharmaceutics|September 28, 2024
Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral StrategiesDebora Obergfäll, Markus Wild, Mona Sommerer, et al.
G3 (Bethesda, Md.)|April 29, 2022
A genome-wide association and prediction study in grapevine deciphers the genetic architecture of multiple traits and identifies genes under many new QTLsTimothée Flutre, Loïc Le Cunff, Agota Fodor, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2014
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS studyFrank Lehner, Klemens Budde, Martin Zeier, et al.
Pageof 43